Par Pharmaceutical Companies, Inc. (NYSE:PRX)

CAPS Rating:

The Company, through its subsidiary Par Pharmaceutical, Inc., is engaged in the development, manufacture and distribution of generic pharmaceuticals and branded pharmaceuticals in the United States.